Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spinal Morphine for Post-VATS Pain
NCT01979354Phase 4
Key facts
- Status
- Unknown
- Start
- Feb 2014
- Primary completion
- Dec 2016
- Countries
- 1
- Sponsor
- Mahidol University
- Modality
- Small Molecules
- Drugs
- morphine
- Conditions
- postoperative pain
01
Overview
Phase 4, randomised, open-label trial of morphine in postoperative pain (2 arms), sponsored by Mahidol University. Primary endpoint: Total morphine requirement in 48 hours. Status: unknown.
02
Design
2 arms- Study design
- RandomizedOpen-label
Spinal morphine
0.15 mg spinal morphine
Control
No spinal morphine
03
Who it enrols
Adult patients (ASA I-III) scheduled for VATS lobectomy or blebectomy who can operate a PCA device.
04
Endpoints
Primary
Total morphine requirement in 48 hours
Secondary
Pain
Beyond the preview
Go deeper on NCT01979354.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01979354.